Replies to post #112365 on Biotech Values

[mcbio]

"it was a wonderful year for the US generics with the launch of venlafaxine [effexor] that really gave us a push in profits and profitability. we're not going to see that kind of launch in 2011 but instead of that we're going to have a long list of much smaller products

Excellent catch. That's very interesting (and telling, I agree).